Navigation Links
IGEN Networks appoints directors and provides business update
Date:2/26/2010

IGEN Networks Corp. (IGEN: OTCBB)

LAS VEGAS, Feb. 26 /PRNewswire-FirstCall/ - IGEN Networks Corp. is pleased to announce the appointment of two new directors, Monty Ormsby, as the new President and Michael Grudman as the new CFO and Secretary. The Company regrets to report the recent passing of one of its directors, Jim Fitzpatrick, and acknowledges his prior contributions to the corporation. John Moore will step down as the Company's President and CFO, but will remain as an interim director.

The Company would also like to release highlights of the new direction for IGEN. The Company has undertaken discussions with a bio-technology company and intends to acquire the global licensing of a patented animal diagnostic test which is in the final stages of completion.

The Company has entered into consulting agreements with Stuart Brame, and Ron Loudoun to assist the Board in determining, identifying and acquiring sustaining business elements for the Company. Additionally, the Company has engaged Pro-Act Management Inc. to provide consulting services with relation to corporate planning and compliance matters.

The Company will pursue raising new capital to finance the contemplated acquisition and development of the bio-technology and to pay-down its current liabilities. Further details of the planned acquisition and financing will be announced as they develop.

On behalf of the Board of Directors

IGEN Networks Corp.

"Monty Ormsby"

President

Safe Harbour Statement under the United States Private Securities Litigation Act of 1995; This release made may contain forward-looking statements that are affected by known and unknown risk, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed, implied or anticipated by such forward-looking statement. The Company does not intend to update this information and disclaims any legal liability to the contrary.

SOURCE iGen Networks Corp.

Back to top
'/>"/>
SOURCE iGen Networks Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
2. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference
3. Palladian Muscular Skeletal Health (formerly Prism Health Networks) to Promote Collaborative, Expanded Practice Model at Major Insurance Conference in June
4. Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy
5. Healthy Advice Networks Announces Improved Patient Outcomes in Physicians Offices with Healthy Advice Programs
6. iSource Networks Partners with inVentiv Health to Develop New Technology Platform for Reaching Healthcare Consumers
7. Smallest nanoantennas for high-speed data networks
8. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
9. Codexis Appoints Singapore Laboratories Managing Director
10. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... San Diego, CA (PRWEB) , ... June 27, 2016 , ... ... mClinical solutions for clinical trials, announced today the Clinical Reach Virtual Patient ... and their care circle with the physician and clinical trial team. , Using the ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):